COVID-19 and Pregnancy: Understanding the Elevated Risks

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, belongs to a family of coronaviruses – specifically the beta-coronavirus group – that includes similar pathogens like Middle East Respiratory Syndrome Coronavirus (MERS-cov) and the original SARS-CoV. This family is known for its potential to trigger widespread pandemics. Pregnancy introduces a uniquely vulnerable state for women, characterized by notable physiological adaptations, especially within the immune and respiratory systems.

The Physiological Impact of Pregnancy on Infection Risk

During pregnancy, a woman’s body undergoes considerable changes to support fetal development. One key alteration is a natural reduction in lung capacity, approximately 20-30%, due to the growing uterus pressing on the diaphragm. This diminished respiratory reserve makes expectant mothers inherently more susceptible to respiratory infections like pneumonia.Coupled with a modulated immune response – a necessary adaptation to prevent rejection of the fetus – pregnant individuals experience a compromised ability to fight off infections, including SARS-CoV-2.

Recent data from the centers for Disease Control and Prevention (CDC) indicates that, while rates of COVID-19 infection have fluctuated with variants, pregnant individuals consistently demonstrate a higher risk of hospitalization compared to non-pregnant women of similar age. For example, during the Delta variant surge in 2021, pregnant women hospitalized with COVID-19 where 1.3 times more likely to require intensive care unit (ICU) admission.

Increased severity of COVID-19 in Pregnant Individuals

The heightened vulnerability translates into a greater likelihood of severe COVID-19 outcomes for pregnant women. Studies have shown a considerably increased risk of needing critical care interventions, such as admission to the ICU, mechanical ventilation (including procedures like endotracheal intubation), and even extracorporeal membrane oxygenation (ECMO) – a life support system that oxygenates the blood outside the body. Tragically, this also correlates with a higher risk of maternal mortality.

Consider the analogy of a ship navigating a storm. A fully crewed, structurally sound vessel can withstand considerable turbulence.However, a ship with a reduced crew (compromised immune system) and structural modifications (decreased lung capacity) is far more vulnerable to damage and potential sinking. Similarly, a pregnant woman’s body, while remarkably resilient, faces increased challenges when battling a severe infection like COVID-19.

beyond Maternal Health: Potential Fetal Implications

The risks aren’t limited to the mother. While vertical transmission – the passage of the virus from mother to baby – is considered relatively uncommon, it is possible, particularly during labor and delivery. furthermore,maternal COVID-19 infection has been linked to an increased risk of preterm birth,stillbirth,and other adverse pregnancy outcomes. A 2021 study published in Clinical Infectious Diseases highlighted a potential association between severe maternal COVID-19 and an elevated risk of placental abnormalities.

Protecting Expectant Mothers: Vaccination and Precautions

Given these elevated risks, vaccination against COVID-19 is strongly recommended for pregnant individuals by leading health organizations like the American College of Obstetricians and Gynecologists (ACOG) and the CDC. Extensive data now demonstrates the safety and efficacy of COVID-19 vaccines during pregnancy, with no evidence of increased risk of miscarriage, stillbirth, or birth defects.

Beyond vaccination, continued adherence to preventative measures – including mask-wearing in public indoor settings, practicing good hand hygiene, and maintaining physical distancing – remains crucial for protecting expectant mothers and their developing babies.Proactive interaction with healthcare providers is also essential to address individual risk factors and ensure optimal prenatal care throughout the pandemic.

Navigating Pregnancy in the Age of COVID-19: Risks, Vaccination, and Emerging Data

The COVID-19 pandemic has presented unique challenges for expectant mothers, raising concerns about potential impacts on both maternal health and fetal development. While initial uncertainty surrounded the virus’s effects on pregnancy, a growing body of research now clearly demonstrates a link between COVID-19 infection during pregnancy and an increased risk of adverse outcomes. Understanding these risks, alongside the protective benefits of vaccination, is crucial for informed decision-making throughout pregnancy.

The Elevated Risks of COVID-19 During Pregnancy

Numerous studies have established that contracting COVID-19 while pregnant isn’t simply a more severe case of the flu; it carries specific risks not typically associated with other respiratory infections. Data consistently points to a higher likelihood of developing pregnancy complications such as pre-eclampsia – a dangerous condition characterized by high blood pressure and organ damage – and preterm labor, potentially leading to premature birth. Furthermore, there’s an observed increase in the need for cesarean deliveries and, tragically, a heightened risk of stillbirth among those infected with the virus.

For example, a large multinational cohort study, INTERCOVID, revealed significantly higher rates of maternal morbidity and mortality among pregnant women with COVID-19 compared to their uninfected counterparts [14]. Similarly, analyses of hospital admissions in the UK have shown a disproportionate number of pregnant women requiring intensive care due to COVID-19 [17]. These findings aren’t isolated incidents; they represent a pattern observed across diverse populations and healthcare systems. As of late 2023, the CDC reports that pregnant people who contract COVID-19 are at a significantly higher risk of hospitalization compared to non-pregnant individuals of reproductive age.

Why is Pregnancy a Risk Factor for Severe COVID-19?

The increased vulnerability of pregnant individuals to severe COVID-19 stems from the physiological changes inherent to pregnancy. The immune system undergoes natural suppression to prevent rejection of the developing fetus, potentially making pregnant women more susceptible to viral infections. Additionally, the physical changes of pregnancy – such as increased oxygen demand and reduced lung capacity – can exacerbate the respiratory distress caused by COVID-19. Think of it like running a marathon while already carrying a heavy load; the body is already working harder, leaving less reserve to fight off illness.

The Protective Power of Vaccination: A Beacon of Hope

Fortunately, COVID-19 vaccines have proven to be a powerful tool in mitigating the risks associated with pregnancy. Extensive research, including studies from Scotland and large-scale analyses of vaccinated pregnant women, demonstrates that vaccination significantly reduces the likelihood of severe illness, hospitalization, and adverse pregnancy outcomes [10].

Vaccination doesn’t just protect the mother; antibodies generated through vaccination can also cross the placenta, providing some level of protection to the developing baby, particularly against severe illness in the first few months of life. This passive immunity is akin to a temporary shield, offering crucial protection before the infant’s own immune system fully matures. Current recommendations from leading health organizations, including the CDC and the American College of obstetricians and Gynecologists (ACOG), strongly advise COVID-19 vaccination for all pregnant individuals, regardless of trimester.

Staying Informed and Proactive: A Path Forward

The landscape of COVID-19 is constantly evolving, with new variants emerging and our understanding of the virus deepening. Pregnant individuals should remain vigilant,staying informed about current public health recommendations and practicing preventative measures such as frequent handwashing,mask-wearing in crowded indoor settings,and maintaining social distancing when possible.

Open communication with healthcare providers is paramount. Discussing individual risk factors, vaccination status, and any concerns is essential for developing a personalized plan to ensure a healthy pregnancy and a safe delivery. While the pandemic has undoubtedly added complexity to pregnancy, proactive measures and informed decision-making can empower expectant mothers to navigate this challenging time with confidence.

Protecting Two lives: COVID-19 Vaccination and Pregnancy – A Global Perspective

The emergence of COVID-19 presented unique challenges to healthcare systems worldwide, particularly concerning the health of pregnant individuals and their developing babies. Early in the pandemic, limited understanding of the virus’s impact on pregnancy, coupled with the exclusion of expectant mothers from initial vaccine trials, created a period of significant uncertainty. However, mounting evidence quickly demonstrated a heightened risk of severe illness and mortality from COVID-19 for pregnant women, necessitating a swift and focused response to develop and implement effective vaccination strategies.

The Vulnerability of Pregnancy During a Pandemic

Pregnancy inherently involves physiological changes that can increase susceptibility to respiratory infections. The presence of the developing fetus and the accompanying hormonal and immunological shifts create a complex environment, making pregnant women more vulnerable to severe complications from viral illnesses. This vulnerability was tragically borne out by early data; a study in Scotland, for example, revealed that pregnant women experienced higher rates of COVID-19 infection compared to both younger and older non-pregnant women, particularly those in disadvantaged communities. This disparity underscored the need for targeted protection.

A Rapidly Evolving Landscape of Vaccine Development

Recognizing the urgent need for intervention, the global scientific community embarked on an unprecedented effort to develop COVID-19 vaccines. By July 2021, over 184 vaccine candidates were in preclinical development, with more than 100 undergoing clinical trials and 18 having received emergency use authorization. A diverse range of vaccine technologies emerged, including mRNA vaccines (like Pfizer and Moderna), viral vector vaccines (like AstraZeneca), inactivated virus vaccines (like Sinopharm), and protein subunit vaccines.

Inactivated virus vaccines,which utilize a killed version of the virus to stimulate an immune response,became a cornerstone of vaccination programs in many countries. These vaccines, such as Sinopharm, are produced by rendering the virus incapable of replication through methods like heat or chemical treatment, while still preserving its ability to trigger protective antibodies. Globally, inactivated virus vaccines have been widely administered due to their established manufacturing processes and relative ease of distribution.

Evidence Mounts: The Safety and Benefits of Vaccination

As vaccination campaigns rolled out, real-world data began to accumulate, providing crucial insights into the safety and efficacy of COVID-19 vaccines during pregnancy. A compelling analysis revealed a stark correlation between vaccination status and perinatal outcomes: all reported perinatal fatalities were among unvaccinated women who contracted COVID-19.

Further bolstering confidence, studies demonstrated no increased risk of adverse events – including miscarriage, preterm birth, maternal mortality, intensive care unit admissions, low birth weight, or neonatal intensive care unit admissions – associated with COVID-19 vaccination. In fact, a systematic review indicated a reduction in the rate of stillbirths among vaccinated individuals. Notably, research on the Pfizer vaccine also suggested a potential benefit: a decreased incidence of meconium staining of amniotic fluid in vaccinated mothers.

Implementation Strategies: the iranian Experience

Iran initiated its COVID-19 vaccination program for pregnant women in August 2021, prioritizing those in later stages of gestation (beyond 28 weeks) and utilizing the Sinopharm vaccine. Initial guidelines recommended vaccination after 12 weeks of pregnancy. However, as more data became available, these guidelines were revised in December 2021 to remove contraindications for vaccination during the first trimester. Moreover, women who had received their first dose of the AstraZeneca vaccine prior to discovering their pregnancy were permitted to complete the two-dose series. This adaptive approach reflects the evolving understanding of vaccine safety and the commitment to protecting both maternal and fetal health.

The global experience with COVID-19 vaccination during pregnancy underscores the importance of proactive public health measures, rapid scientific innovation, and a commitment to evidence-based decision-making. Protecting pregnant individuals from severe illness not only safeguards their own well-being but also contributes to healthier outcomes for their babies.## Evaluating COVID-19 Vaccine Impact on Pregnancy: A Retrospective Cohort study

The COVID-19 pandemic presented unique challenges for pregnant women, raising concerns about both maternal and neonatal health. While rapid vaccine development offered a crucial tool in combating the virus, initial data regarding vaccine safety and efficacy specifically within this population remained limited. despite a growing body of research – including a 2021 systematic review^31,32 – substantial gaps persist in understanding the effects of COVID-19 vaccination on pregnancy outcomes. This is particularly true when considering the diverse range of vaccines used globally,with much of the early research focusing on mRNA-based vaccines like Pfizer and Moderna⁴. Recognizing this knowledge deficit, and the relative lack of studies conducted within the Iranian context, this research aimed to comprehensively compare maternal and neonatal outcomes between pregnant women who received COVID-19 vaccination and those who remained unvaccinated, ultimately seeking to address critical uncertainties surrounding vaccine impact.

### Study Design and Setting

This investigation utilized a retrospective cohort design, conducted in Rafsanjan City during 2023. The study protocol received full ethical approval from the Research Committee of Rafsanjan University of Medical Sciences, under ethics code IR.RUMS.REC.1402.064.Data was extracted over a six-month period (June 22, 2021 – December 22, 2021) from the Integrated Health System of Iran (sib), a national health information database. Initially, records for 969 pregnant women were identified. Researchers initiated contact with each potential participant via telephone, explaining the study’s objectives, assuring data confidentiality, verifying eligibility, and obtaining informed consent. Eligible participants then completed a standardized questionnaire. The informed consent process emphasized the protection of personal information and clarified that all findings would be presented in aggregate form, without any identifying details.

To maximize participation and minimize bias, a multi-stage contact approach was employed. Individuals who did not respond to the initial phone call received a text message outlining the study and researcher contact information,followed by a second phone call attempt. Non-responders after these efforts were excluded from the study.Given the potential for recall bias regarding vaccination dates and specific vaccine types,all reported vaccination information was cross-referenced with records within the Sib system. Similarly, discrepancies between self-reported Last Menstrual Period (LMP) and gestational age at delivery were resolved by reviewing the first recorded ultrasound data available in the Sib system. This rigorous verification process resulted in a final sample size of 610 participants with complete and validated data.

### Data Collection and Categorization

Following data validation, participants were divided into two distinct groups: those who had received COVID-19 vaccination during pregnancy and those who remained unvaccinated. Each participant was assigned a unique identifier to maintain anonymity.Complete data on a range of maternal and neonatal outcomes were then collected and analyzed. These outcomes included: hypertensive disorders of pregnancy (such as preeclampsia and gestational hypertension), gestational diabetes mellitus, maternal hospitalization during pregnancy, maternal COVID-19 infection, premature rupture of membranes, preterm labor, mode of delivery (vaginal versus cesarean section), pregnancy loss (miscarriage or stillbirth), maternal mortality, perinatal mortality, low birth weight, neonatal jaundice, admission to the Neonatal Intensive Care Unit (NICU), and neonatal sepsis.

The analysis considered not only vaccination status but also detailed information regarding vaccine type, the number of doses received, and the gestational timing of vaccination. For context, as of December 2023, over 5.3 billion doses of COVID-19 vaccines have been administered globally, with mRNA vaccines representing a significant portion of the doses delivered in many countries.

### Statistical Analysis

Statistical analysis was performed using SPSS version 26. One-way analysis of Variance (ANOVA) was utilized to assess potential relationships between maternal age and the type of COVID-19 vaccine received.

Analyzing the Impact of Vaccination and Maternal characteristics on Pregnancy Outcomes

Understanding the factors influencing both maternal and neonatal health is crucial, particularly considering recent global health events. This analysis investigates the connections between maternal occupation, educational attainment, vaccination status (type and dosage), timing of vaccination during pregnancy, and a range of pregnancy and birth outcomes. The study aims to identify potential associations and contribute to informed healthcare practices.

Statistical Methods Employed

To determine if relationships existed between a mother’s profession and education level and the type of COVID-19 vaccine received, Fisher’s exact test was utilized. This test is particularly useful when dealing with smaller sample sizes or categorical data, ensuring robust analysis.

However, the core of the investigation focused on evaluating how vaccination characteristics – including the specific vaccine administered, the number of doses received, and when during pregnancy vaccination occurred – correlated with various maternal and neonatal outcomes. To achieve this,multiple logistic regression modeling was implemented. This complex statistical technique allowed researchers to simultaneously assess the influence of vaccination factors while controlling for potential confounding variables.These variables, which could independently affect outcomes, were accounted for to isolate the specific impact of vaccination.

Outcomes under Investigation

The study comprehensively examined a spectrum of maternal health outcomes, including:

Delivery Method: Cesarean section rates.
Pregnancy Loss: Incidence of miscarriage.
Maternal Complications: Hospitalization during pregnancy, maternal COVID-19 infection, hypertensive disorders of pregnancy (like preeclampsia), and gestational diabetes.
Labor & Delivery Complications: Preterm labor and premature rupture of membranes.

Alongside maternal outcomes, the analysis also scrutinized key neonatal indicators:

Perinatal Mortality: Deaths occurring around the time of birth. According to the CDC, the US perinatal mortality rate was 5.96 per 1,000 live births in 2022, highlighting the importance of identifying modifiable risk factors.
Neonatal Intensive Care Unit (NICU) Admission: The need for specialized care promptly after birth.
Neonatal Jaundice: A common condition requiring monitoring and potential treatment.
Birth Weight: Incidence of low birth weight, a significant predictor of infant health.

Interpreting the Results

The results of the logistic regression analyses are presented as odds ratios (OR) alongside 95% confidence intervals. An odds ratio indicates the strength and direction of the association between vaccination characteristics and the outcome being studied. For example, an OR of 1.5 suggests a 50% increased odds of the outcome occurring in vaccinated individuals compared to unvaccinated individuals,after accounting for other factors.

A p-value of less than 0.05 was established as the threshold for statistical significance. This means that any observed association with a p-value below 0.05 is unlikely to have occurred by chance, suggesting a genuine relationship between the variables. The rigorous application of these statistical criteria ensures the reliability and validity of the study’s findings, contributing to a more nuanced understanding of the complex interplay between vaccination and pregnancy outcomes.

COVID-19 Vaccination in Pregnancy: Maternal & Neonatal Outcomes

The COVID-19 pandemic has presented unprecedented challenges, especially for pregnant women. Concerns about the safety and efficacy of COVID-19 vaccination during pregnancy have been widespread. This article aims to provide a extensive overview of the current evidence regarding maternal and neonatal outcomes following COVID-19 vaccination while pregnant.We’ll delve into the research, address common anxieties, and offer insights into how vaccination can protect both mother and child.

Why is COVID-19 Vaccination in Pregnancy Crucial?

Pregnancy alters the immune system and respiratory function, making expectant mothers more susceptible to severe illness from COVID-19.Compared to non-pregnant individuals, pregnant women with COVID-19 face a higher risk of:

• Hospitalization
• ICU admission
• Ventilator use
• Death
• Preterm birth
• Stillbirth

Therefore, COVID-19 vaccination recommendations for pregnant women are crucial in mitigating these risks and safeguarding their health and the health of their babies. COVID vaccination for pregnant women serves as a preventative measure against these perhaps serious complications.

Current Recommendations from Health Organizations

Leading health organizations worldwide, including the Centers for Disease Control and prevention (CDC), the World Health Organization (WHO), and the American College of Obstetricians and Gynecologists (ACOG), strongly recommend COVID-19 vaccination for all pregnant individuals, those planning to become pregnant, and those who are breastfeeding. These recommendations are based on extensive evidence demonstrating the safety and effectiveness of the vaccines in this population. The official stance is that the benefits of vaccination far outweigh any potential risks associated with COVID vaccines during pregnancy.

Safety Data: What Does the Research Say?

Numerous studies have assessed the safety of COVID-19 vaccines in pregnant women. These studies have consistently shown that the vaccines are safe and well-tolerated. Crucially, the data shows no increased risk of adverse pregnancy outcomes, such as:

• Miscarriage
• Preterm birth
• Stillbirth
• Birth defects

The initial concerns about potential harms have been largely dispelled by robust scientific evidence. Active surveillance systems and large-scale cohort studies continue to monitor the safety of COVID vaccination and pregnancy outcomes.

Efficacy of COVID-19 vaccines During Pregnancy

Beyond safety, the efficacy of COVID-19 vaccines in preventing severe disease in pregnant women has been well-documented. Studies have shown that vaccinated pregnant individuals are significantly less likely to be hospitalized or require intensive care due to COVID-19 infection. Furthermore, vaccination during pregnancy can also provide passive immunity to the newborn. Antibodies produced by the mother in response to the vaccine can cross the placenta and protect the baby in the first few months of life when they are most vulnerable to severe COVID-19.

Maternal Outcomes Following COVID-19 Vaccination

Research focusing on COVID-19 vaccine maternal outcomes provides compelling evidence of benefits. Vaccinated pregnant women experience:

• Reduced risk of severe COVID-19 illness
• Lower rates of hospitalization and ICU admission
• Decreased need for mechanical ventilation
• improved overall health outcomes compared to unvaccinated pregnant women who contract COVID-19

The impact of COVID vaccine side effects in pregnant women is generally mild and similar to those experienced by non-pregnant individuals, including pain at the injection site, fatigue, headache, and fever.These side effects are typically short-lived and resolve on their own.

Neonatal Outcomes Following COVID-19 Vaccination

The positive effects of COVID-19 vaccination extend beyond maternal health to benefit the newborn. Studies on neonatal outcomes of COVID vaccination demonstrate several advantages:

• Passive immunity: Infants born to vaccinated mothers have detectable antibodies against SARS-CoV-2 at birth, providing protection against infection in early infancy.
• Reduced risk of infant hospitalization: Emerging evidence suggests that vaccination during pregnancy may decrease the risk of COVID-19-related hospitalization in infants.
• Improved birth outcomes: Some studies have indicated a potential association between vaccination and a reduced risk of preterm birth, although more research is ongoing in this area.

COVID vaccination in pregnancy and impact on newborns is a growing area of research, and the initial findings are encouraging, suggesting that vaccination confers important benefits to infants.

Addressing Common Concerns and Misconceptions

Despite the overwhelming evidence supporting the safety and efficacy of COVID-19 vaccination during pregnancy, some anxieties and misinformation persist.It’s important to address these concerns with accurate information:

• Misconception: COVID-19 vaccines can cause miscarriage. Fact: Studies have shown no increased risk of miscarriage following vaccination.
• Misconception: the vaccines are too new to be safe during pregnancy. Fact: While the vaccines were developed relatively quickly, they underwent rigorous clinical trials and have been administered to millions of pregnant women worldwide with no significant safety concerns.
• Misconception: The vaccines can harm the baby. Fact: There is no evidence to suggest that the vaccines cause harm to the developing fetus. In contrast, vaccination can protect the baby by providing passive immunity.

Open interaction with healthcare providers is crucial for addressing individual concerns and making informed decisions about vaccination.

Types of COVID-19 Vaccines Recommended During pregnancy

The mRNA vaccines (Pfizer-BioNTech and Moderna) and the adenovirus vector vaccine (Johnson & Johnson/Janssen, even though less frequently used now) have all been recommended for use during pregnancy based on safety and efficacy data. However, mRNA vaccines are generally preferred. The specific vaccine type should be discussed with a healthcare provider.Boosters are also recommended for pregnant individuals to maintain optimal protection against evolving variants of the virus. staying up to date on COVID vaccine pregnancy recommendations ensures the best possible protection.

Practical Tips for Pregnant Women Considering Vaccination

Here are some practical tips for pregnant women considering COVID-19 vaccination:

• Talk to your doctor or othre healthcare provider. Discuss your concerns, ask questions, and get personalized advice.
• Stay informed. Rely on trusted sources of information,such as the CDC,WHO,and ACOG.
• schedule your vaccination as soon as possible. The sooner you are vaccinated,the sooner you and your baby will be protected.
• Monitor for side effects after vaccination. Most side effects are mild and temporary.
• Continue to practise other preventative measures, such as wearing a mask, washing your hands frequently, and maintaining social distancing, especially in areas with high transmission rates.

Benefits Highlighted

• Reduced risk of severe COVID-19 for the mother
• Passive immunity transfer to the baby, offering early protection
• Potentially reduced risk of preterm birth
• Overall peace of mind knowing you’ve taken steps to protect yourself and your child

Case Studies

While maintaining patient confidentiality, numerous anecdotes and case studies reinforce the benefits of COVID vaccination in pregnancy.

Case 1: A 32-year-old pregnant woman, vaccinated with two doses of an mRNA vaccine in her second trimester, contracted COVID-19 in her third trimester.Her symptoms were mild, and she recovered quickly at home without requiring hospitalization. Her baby was born healthy and had detectable antibodies against SARS-CoV-2.

Case 2: A 28-year-old unvaccinated pregnant woman contracted COVID-19 in her third trimester and developed severe pneumonia, requiring hospitalization and mechanical ventilation. She experienced a intricate pregnancy and delivered preterm. Her baby also faced health challenges due to the prematurity.

These contrasting scenarios,though generalized,highlight the potential protective benefits of COVID vaccination during pregnancy.

Firsthand Experience: one Mom’s Story

“I was hesitant at first,worried about how the COVID vaccine might affect my pregnancy.But after talking to my doctor and reading the research, I felt confident that getting vaccinated was the right decision for me and my baby. I experienced mild side effects after the second dose, like a sore arm and some fatigue. But knowing that I was protecting myself and giving my baby a head start with antibodies made it all worth it. I delivered a healthy baby girl, and I’m so grateful I made the decision to get vaccinated.” – *Anonymous*

Ongoing Research and Future Directions

research on COVID-19 vaccination in pregnancy is ongoing and evolving. Future studies will focus on:

• Long-term effects of vaccination on maternal and child health
• Optimal timing of vaccination during pregnancy
• Effectiveness of booster doses against emerging variants
• Impact of vaccination on breastfeeding outcomes

Staying informed about the latest research findings is essential for making evidence-based decisions about COVID vaccination during pregnancy.

Conclusion

The overwhelming evidence supports the safety efficacy of COVID-19 vaccination during all stages in pregnancy. Protecting pregnant women, who are among the population most at risk to COVID-19 complications, is the key.With the newest studies the confidence in COVID-19 vaccine is increasing every day.

Variable	Vaccinated Pregnant Women	Unvaccinated Pregnant Women
Hospitalization Rate (COVID-19)	lower	Higher
Premature Birth Rate	Similar or Slightly Lower	Potentially Higher
Infant COVID-19 Antibodies	Present	Absent or Low

The post COVID-19 Vaccination in Pregnancy: Maternal & Neonatal Outcomes appeared first on Archynewsy.

Source link